• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prevalence and correlates of diabetes mellitus and dyslipidaemia in a long-stay inpatient schizophrenia population in Singapore.新加坡长期住院精神分裂症患者人群中糖尿病和血脂异常的患病率及其相关因素
Singapore Med J. 2018 Sep;59(9):465-471. doi: 10.11622/smedj.2018020. Epub 2018 Feb 12.
2
Comment on: Prevalence and correlates of diabetes mellitus and dyslipidaemia in a long-stay inpatient schizophrenia population in Singapore.关于《新加坡长期住院精神分裂症患者人群中糖尿病和血脂异常的患病率及其相关因素》的评论
Singapore Med J. 2019 Feb;60(2):104. doi: 10.11622/smedj.2019018.
3
High Prevalence of Obesity, Hypertension, Hyperlipidemia, and Diabetes Mellitus in Japanese Outpatients with Schizophrenia: A Nationwide Survey.日本精神分裂症门诊患者中肥胖、高血压、高脂血症和糖尿病的高患病率:一项全国性调查。
PLoS One. 2016 Nov 17;11(11):e0166429. doi: 10.1371/journal.pone.0166429. eCollection 2016.
4
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].[制定重症精神疾病患者身体健康检查指南]
Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9.
5
Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.慢性精神分裂症住院患者中糖尿病的患病率与长期抗精神病药物治疗的关系。
Eur Neuropsychopharmacol. 2006 Apr;16(3):187-94. doi: 10.1016/j.euroneuro.2005.09.003. Epub 2005 Nov 2.
6
Differential trends in prevalence of diabetes and unrelated general medical illness for schizophrenia patients before and after the atypical antipsychotic era.非典型抗精神病药物时代前后精神分裂症患者糖尿病患病率及非相关普通内科疾病的差异趋势。
Schizophr Res. 2006 Sep;86(1-3):99-109. doi: 10.1016/j.schres.2006.04.014. Epub 2006 Jun 6.
7
Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients.糖尿病和血脂异常与氧化应激有关,与长期接受抗逆转录病毒治疗的 HIV 感染患者的炎症无关。
Diabetes Metab. 2019 Dec;45(6):573-581. doi: 10.1016/j.diabet.2019.02.008. Epub 2019 Mar 9.
8
Metabolic syndrome and cardiovascular risk among institutionalized patients with schizophrenia receiving long term tertiary care.代谢综合征与长期接受三级护理的住院精神分裂症患者心血管风险。
Compr Psychiatry. 2017 Apr;74:196-203. doi: 10.1016/j.comppsych.2017.01.017. Epub 2017 Feb 2.
9
[Survey of obesity and underweight among inpatients with schizophrenia in psychiatric hospitals throughout Japan].[日本各地精神病院精神分裂症住院患者肥胖与体重过轻情况调查]
Seishin Shinkeigaku Zasshi. 2013;115(1):10-21.
10
Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases.法国银屑病患者的代谢合并症和高血压。与法国国家数据库的比较。
Ann Dermatol Venereol. 2016 Apr;143(4):264-74. doi: 10.1016/j.annder.2015.06.024. Epub 2016 Mar 8.

引用本文的文献

1
Clinical Patterns of Dyslipidemia in Patients With Initial-Treatment and Drug-Naïve Schizophrenia.初治及未用药精神分裂症患者血脂异常的临床模式
Alpha Psychiatry. 2025 Aug 26;26(4):46060. doi: 10.31083/AP46060. eCollection 2025 Aug.
2
Validation of the 12-item World Health Organization Disability Assessment Schedule 2.0 in individuals with schizophrenia, depression, anxiety, and diabetes in Singapore.在新加坡,对精神分裂症、抑郁症、焦虑症和糖尿病患者使用 12 项世界卫生组织残疾评估量表 2.0 进行验证。
PLoS One. 2023 Nov 30;18(11):e0294908. doi: 10.1371/journal.pone.0294908. eCollection 2023.
3
Prediction of physiological state, cognition, sensory function, and biomarkers for frailty in patients aged 55 years or more with schizophrenia.预测 55 岁及以上精神分裂症患者的生理状态、认知、感觉功能和脆弱性生物标志物。
Nurs Open. 2023 Aug;10(8):5044-5055. doi: 10.1002/nop2.1741. Epub 2023 Apr 10.
4
Prevalence and correlates of metabolic syndrome and its components in adults with psychotic disorders in Eldoret, Kenya.肯尼亚埃尔多雷特成年人精神障碍患者中代谢综合征及其成分的患病率和相关因素。
PLoS One. 2021 Jan 11;16(1):e0245086. doi: 10.1371/journal.pone.0245086. eCollection 2021.
5
Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medications.使用抗精神病药物治疗的精神分裂症患者代谢综合征的患病率。
Caspian J Intern Med. 2020 May;11(3):310-314. doi: 10.22088/cjim.11.3.310.
6
Authors' reply.作者回复。
Singapore Med J. 2019 Feb;60(2):104. doi: 10.11622/smedj.2019019.
7
Comment on: Prevalence and correlates of diabetes mellitus and dyslipidaemia in a long-stay inpatient schizophrenia population in Singapore.关于《新加坡长期住院精神分裂症患者人群中糖尿病和血脂异常的患病率及其相关因素》的评论
Singapore Med J. 2019 Feb;60(2):104. doi: 10.11622/smedj.2019018.

本文引用的文献

1
Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.抗精神病药、抗抑郁药和心境稳定剂对精神分裂症、抑郁症和双相情感障碍患者身体疾病风险的影响。
World Psychiatry. 2015 Jun;14(2):119-36. doi: 10.1002/wps.20204.
2
Staying relevant with the times--the changing face of an asylum.与时俱进——收容所面貌的变迁
Ann Acad Med Singap. 2014 Oct;43(10):481-3.
3
Dose equivalents for second-generation antipsychotics: the minimum effective dose method.第二代抗精神病药物的剂量当量:最小有效剂量法。
Schizophr Bull. 2014 Mar;40(2):314-26. doi: 10.1093/schbul/sbu001. Epub 2014 Feb 3.
4
Body mass index, obesity, and psychopathology in patients with schizophrenia.体质指数、肥胖与精神分裂症患者的精神病理学。
J Clin Psychopharmacol. 2014 Feb;34(1):40-6. doi: 10.1097/JCP.0000000000000058.
5
Relationship between SSRIs and Metabolic Syndrome Abnormalities in Patients with Generalized Anxiety Disorder: A Prospective Study.广泛性焦虑障碍患者 SSRIs 与代谢综合征异常的关系:一项前瞻性研究。
Psychiatry Investig. 2013 Jun;10(2):148-54. doi: 10.4306/pi.2013.10.2.148. Epub 2013 May 30.
6
Life expectancy and cardiovascular mortality in persons with schizophrenia.精神分裂症患者的预期寿命和心血管死亡率。
Curr Opin Psychiatry. 2012 Mar;25(2):83-8. doi: 10.1097/YCO.0b013e32835035ca.
7
Risk factors for overweight and diabetes mellitus in residential psychiatric patients.住院精神科患者超重和糖尿病的危险因素。
Obes Facts. 2011;4(5):341-5. doi: 10.1159/000333420. Epub 2011 Oct 14.
8
Improving prescribing practice in psychiatry: the experience of the Prescribing Observatory for Mental Health (POMH-UK).改善精神病学的处方实践:心理健康处方观察站(POMH-UK)的经验。
Int Rev Psychiatry. 2011 Aug;23(4):328-35. doi: 10.3109/09540261.2011.606541.
9
Efficacy of lifestyle interventions in physical health management of patients with severe mental illness.生活方式干预对严重精神疾病患者身体健康管理的疗效。
Ann Gen Psychiatry. 2011 Sep 19;10:22. doi: 10.1186/1744-859X-10-22.
10
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.精神疾病患者的躯体疾病。一、患病率、药物影响和医疗保健差异。
World Psychiatry. 2011 Feb;10(1):52-77. doi: 10.1002/j.2051-5545.2011.tb00014.x.

新加坡长期住院精神分裂症患者人群中糖尿病和血脂异常的患病率及其相关因素

Prevalence and correlates of diabetes mellitus and dyslipidaemia in a long-stay inpatient schizophrenia population in Singapore.

作者信息

Shafie Saleha, Lee Siau Pheng, Ong Samantha Bee Cheng, Wang Peizhi, Seow Esmond, Ong Hui Lin, Chong Siow Ann, Subramaniam Mythily

机构信息

Research Division, Institute of Mental Health, Singapore.

Nursing Administration, Institute of Mental Health, Singapore.

出版信息

Singapore Med J. 2018 Sep;59(9):465-471. doi: 10.11622/smedj.2018020. Epub 2018 Feb 12.

DOI:10.11622/smedj.2018020
PMID:29430576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6158135/
Abstract

INTRODUCTION

Patients with schizophrenia have shorter life expectancy and one of the main causes of death is cardiovascular disease (CVD). Modifiable risk factors for CVD include diabetes mellitus (DM) and dyslipidaemia. This study aimed to establish: (a) the prevalence and correlates of DM and dyslipidaemia; (b) the proportion of those whose condition was well controlled; and (c) the incidence of undiagnosed DM and dyslipidaemia in a long-stay inpatient schizophrenia population.

METHODS

Data was collected to assess the physical health status of 110 inpatients with schizophrenia who had been in hospital for over one year. Information on sociodemographic characteristics, diagnosis of physical and mental illnesses, and current medications was obtained from their medical records. The overall prevalence of DM and dyslipidaemia was based on diagnosis in the medical records, current medications and fasting blood test results.

RESULTS

The patient group was predominantly male (85.5%), with a mean age of 55.9 ± 9.9 (range 25-90) years. Overall prevalence of DM and dyslipidaemia was 19.1% and 62.7%, respectively. Multivariate logistic regression analysis showed that Malay (odds ratio [OR] 14.97) and Indian (OR 25.71) patients were significantly more likely to have DM when compared to Chinese patients.

CONCLUSION

In comparison to the general population, the prevalence of DM and dyslipidaemia was found to be higher in inpatients with schizophrenia. However, the two chronic illnesses were well controlled in inpatients and few were undiagnosed, perhaps due to the regular monitoring, supervised diet and regular physical activities arranged for inpatients in the long-stay inpatient wards.

摘要

引言

精神分裂症患者的预期寿命较短,主要死因之一是心血管疾病(CVD)。CVD的可改变风险因素包括糖尿病(DM)和血脂异常。本研究旨在确定:(a)DM和血脂异常的患病率及其相关因素;(b)病情得到良好控制的患者比例;(c)长期住院的精神分裂症患者中未被诊断出的DM和血脂异常的发生率。

方法

收集数据以评估110名住院超过一年的精神分裂症患者的身体健康状况。从他们的病历中获取社会人口学特征、身心疾病诊断和当前用药信息。DM和血脂异常的总体患病率基于病历诊断、当前用药情况和空腹血液检查结果。

结果

患者组以男性为主(85.5%),平均年龄为55.9±9.9岁(范围25 - 90岁)。DM和血脂异常的总体患病率分别为19.1%和62.7%。多因素逻辑回归分析显示,与中国患者相比,马来族(优势比[OR] 14.97)和印度族(OR 25.71)患者患DM的可能性显著更高。

结论

与普通人群相比,精神分裂症住院患者中DM和血脂异常的患病率更高。然而,这两种慢性病在住院患者中得到了良好控制,未被诊断出的患者很少,这可能是由于长期住院病房为患者安排了定期监测、监督饮食和定期体育活动。